# US 2004/0018148 A1 · Stable radioiodine conjugates and methods of their synthesis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0018148 A1
- Document ID: US20040018148A1
- Status: Published application
- Kind: A1
- Application number: 10/395,718
- Filed: 2003-03-25
- Published: 2004-01-29
- Earliest claimed: 1996-08-28
- Assignees: Immunomedics, Inc.
- Inventors: Serengulam V. Govindan; Gary L. Griffiths
- Web page: https://patentgrep.com/patent/US20040018148A1

## CPC

- A61K 51/0491: {Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers}
- A61K 51/088: {conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10)}
- A61K 51/10: Antibodies or immunoglobulins; Fragments thereof {, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody}
- A61K 51/1093: {conjugates with carriers being antibodies}
- C07H 3/04: Disaccharides
- C07K 1/1077: {by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids}
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods are described for conjugating radioiodinated peptides or carbohydrate structures to proteins with improved yields and qualities of conjugates. In one method, specially designed radioiodinated bifunctional peptides containing nonmetabolizable amide bonds are coupled to antibodies. In a second method, radioiodinated nonmetabolizable bifunctional peptides, which also contain aminopolycarboxylates, are coupled to antibodies. In a third method, radioiodinated bifunctional aminopolycarboxylates are coupled to antibodies. In a fourth method, a hydrazide-appended antibody is coupled to a radioiodinated carbohydrate or a thiolated antibody is coupled to a hydrazide-appended and radioiodinated carbohydrate. In a fifth method a monoderivatized cyanuric chloride is used to conjugate thiolated antibody. Radioiodinated residualizing antibody conjugates made by these methods are particularly stable in vivo and are suitable for radioimmunodetection and radioimmunotherapy.

## Claims

### Claim 1

An aminopolycarboxylate-appended peptide useful for radioiodinating an antibody, comprising:
(a) a peptide that comprises at least one D-tyrosine or tyramine, an amino terminus, a carboxy terminus formed from a D-lysine and no contiguous L-amino acids between the D-tyrosine or tyramine and the carboxy terminus;
(b) an aminopolycarboxylate conjugated via one of its carboxylic acid groups to the peptide via an ε-amino group of the D-lysine to form an aminopolycarboxylate-appended peptide; and
(c) a moiety conjugated to said aminopoly-carboxylate-appended peptide and comprising an antibody binding functional group.

### Claim 2 (depends on 1)

The aminopolycarboxylate-appended peptide of claim 1, further comprising a radioiodine atom covalently bound to the D-tyrosine or tyramine residue.

### Claim 3 (depends on 1)

The aminopolycarboxylate-appended peptide of claim 1, wherein said functional group is capable of reacting with a sulfhydryl residue of an antibody to form a covalent bond.

### Claim 4 (depends on 1)

The aminopolycarboxylate-appended peptide of claim 1, wherein said peptide contains 5-40 amino acids.

### Claim 5 (depends on 2)

The radioionated aminopolycarboxylate-appended peptide of claim 2, wherein said peptide contains 5-40 amino acids.

### Claim 6 (depends on 1)

The aminopolycarboxylate-appended peptide of claim 1, wherein said tyramine or D-tyrosine is directly linked to said D-lysine.

### Claim 7 (depends on 1)

The aminopolycarboxylate-appended peptide of claim 1, wherein said aminopolycarboxylate is selected from the group consisting of nitrilotriacetic acid, EDTA, DTPA, TTHA and backbone-substituted derivatives of nitrilotriacetic acid, EDTA, DTPA and TTHA.

### Claim 8

An aminopolycarboxylate-appended peptide useful for radioiodinating an antibody, comprising:
(a) a peptide that comprises at least one D-tyrosine or tyramine, an amino terminus, a carboxy terminus formed from a D-amino acid and no contiguous L-amino acids between the D-tyrosine or tyramine and the carboxy terminus;
(b) an aminopolycarboxylate conjugated via one of its amino groups to the peptide via an amide bond to a peptide carboxylic acid group or via a thiourea bond to a peptide amino acid residue to form an aminopolycarboxylate-appended peptide; and
(c) a moiety conjugated to said aminopolycarboxylate-appended peptide and comprising an antibody binding functional group.

### Claim 9 (depends on 8)

The aminopolycarboxylate-appended peptide of claim 8, wherein said aminopolycarboxylate is selected from the group consisting of nitrilotriacetic acid, EDTA, DTPA, TTHA and backbone-substituted derivatives of nitrilotriacetic acid, EDTA, DTPA and TTHA.

### Claim 10

An aminopolycarboxylate conjugate useful for radioiodinating an antibody, comprising:
(a) an aminopolycarboxylate; and
(b) at least one D-tyrosine or tyramine residue wherein the residue is conjugated via its amino group to a carboxyl group of the aminopolycarboxylate.

### Claim 11 (depends on 10)

The aminopolycarboxylate conjugate of claim 10, further comprising a radioiodine atom covalently bonded to the D-tyrosine or tyramine residue.

### Claim 12 (depends on 10)

The aminopolycarboxylate-appended peptide of claim 10, wherein said aminopolycarboxylate is selected from the group consisting of nitrilotriacetic acid, EDTA, DTPA, TTHA and backbone-substituted derivatives of nitrilotriacetic acid, EDTA, DTPA and TTHA.

### Claim 13

A stable oxidized disaccharide adduct useful for radioiodinating an antibody, comprising:
(a) an oxidized disaccharide that comprises galactose and at least one carbonyl group; and
(b) a D-tyrosine or tyramine.

### Claim 14 (depends on 13)

The stable oxidized disaccharide adduct of claim 13, further comprising a radioiodine atom covalently bound to the D-tyrosine or tyramine.

### Claim 15 (depends on 13)

The stable oxidized disaccharide adduct of claim 13, wherein said disaccharide is selected from the group consisting of dimelibiitoltyramine, melibiitoltyramine, melibiitol-(D)-tyrosine and dimelibiitol-(D)-tyrosine.

### Claim 16 (depends on 13)

The stable oxidized disaccharide adduct of claim 13, further comprising an antibody binding moiety comprising a functional group selected from the group consisting of an aldehyde, an amine, an isothioocyanate, an N-hydroxysuccinimide ester, an imidate ester, a maleimide, a bromoacetamide and an iodoacetamide.

### Claim 17 (depends on 13)

The stable oxidized disaccharide adduct of claim 13, further comprising a monosubstituted cyanuric monochloride.

### Claim 18 (depends on 17)

The stable oxidized disaccharide adduct of claim 17, wherein said cyanuric monochloride is monosubstituted with a maleimide.
